Variable | Overall patients (n = 5161) | Alive (n = 3856) | Death (n = 1305) | p-value | |||
---|---|---|---|---|---|---|---|
Patients | Missing (n) | Patients | Missing (n) | Patients | Missing (n) | ||
Demographic | |||||||
Age median (IQR) | 66 (53–77) | 0 | 62 (48–73) | 0 | 76 (67–84) | 0 | < 0.01* |
Days of hospital stay (IQR) | 8 (4–13) | 0 | 7 (3–12) | 3356 | 11 (5–17) | 655 | < 0.01* |
Days of ICU (IQR) | 9 (4–15) | 3951 | 8 (4–14.5) | 3313 | 9 (5–15) | 638 | 0.016* |
Body mass index median (IQR) | 26.34 (23.46–29.38) | 3 | 26.44 (23.71–29.41) | 2 | 25.84 (23.18–29.35) | 1 | < 0.01* |
Sex | |||||||
Female | 2340 (45.34%) | 0 | 1850 (79.06%) | 0 | 490 (20.94%) | 0 | < 0.01* |
Male | 2821 (54.65%) | 0 | 2006 (71.11%) | 0 | 815 (28.89%) | 0 | < 0.01* |
Management site | |||||||
Inpatient | 2970 (57.54%) | 0 | 2459 (82.79%) | 0 | 511 (17.21%) | 0 | < 0.01* |
ICU | 1223 (23.69%) | 0 | 543 (44.40%) | 0 | 680 (55.60%) | 0 | < 0.01* |
Outpatient | 854 (16.54%) | 0 | 854 (100.00%) | 0 | 0 (0%) | 0 | < 0.01* |
Emergency | 114 (2.20%) | 0 | 0 (0%) | 0 | 114 (100%) | 0 | < 0.01* |
Comorbidities | |||||||
Hypertension | 1171 (22.68%) | 0 | 803 (68.57%) | 0 | 368 (31.43%) | 0 | < 0.01* |
Diabetes types 1 and 2 | 256 (4.96%) | 0 | 163 (63.67%) | 0 | 93 (36.33%) | 0 | < 0.01* |
COPD | 290 (5.61%) | 0 | 158 (54.48%) | 0 | 132 (45.52%) | 0 | < 0.01* |
HIV | 9 (0.17%) | 0 | 7 (77.78%) | 0 | 2 (22.22%) | 0 | - |
Hypothyroidism | 358 (6.93%) | 0 | 247 (68.99%) | 0 | 111 (31.01%) | 0 | 0.011* |
Laboratory values median (IQR) | |||||||
Leukocyte blood count | 7,985 (0.2–262.9) | 439 | 7.75 (5.76–10.51) | 415 | 8.62 (6.22–12.02) | 24 | < 0.01* |
Neutrophil-lymphocyte ratio | 6,0303 (3,4258–10,7008) | 442 | 5.391 (3.131–9.519) | 415 | 8,322 (4,634–14,896) | 27 | < 0.01* |
Haematocrit | 43.4 (39.2–47) | 434 | 43.7 (39.9–47.1) | 410 | 42.5 (36.9–46.7) | 24 | < 0.01* |
Haemoglobin | 14.5 (13–15.8) | 433 | 14.6 (13.3–15.8) | 410 | 14.1 (12.2–15,675) | 23 | < 0.01* |
LDH | 337 (255–445) | 765 | 321 (247–410) | 661 | 400 (288–549) | 104 | < 0.01* |
D-Dimer | 950 (540–1802.25) | 1013 | 857 (497–1490) | 855 | 1296 (721.5–2641.5) | 158 | < 0.01* |
Procalcitonin | 0.31 (0.12–1.01) | 3592 | 0.2 (0.09–0.57) | 2918 | 0.63 (0.24–2,225) | 674 | < 0.01* |
Ferritin | 881 (478–1612.5) | 4834 | 789.5 (417.75–1422,25) | 3642 | 1225 (594–2359) | 1192 | < 0.01* |
Oxygenation values median (IQR) | |||||||
S/F ratio at admission | 339.28 (310.71–423.80) | 166 | 346,429 (321,429–428,571) | 159 | 318,452 (184–361,905) | 7 | < 0.01* |
S/F ratio at 48 h | 325 (254.28–341.52) | 806 | 328,571 (303,333–342,857) | 690 | 281.25 (167,273–328,571) | 116 | < 0.01* |
P/F ratio at admission | 233,3854 (180,9524–274,6429) | 711 | 242,381 (202.5–279,524) | 655 | 191,786 (112.8–254,643) | 56 | < 0.01* |
S/F ratio at ICU admission | 168 (105.55–255.55) | *4011 | 186 (121.25–288,281) | 3356 | 149,615 (95,667–194) | 655 | < 0.01* |
P/F ratio at ICU admission | 118.14 (81.55–171.44) | *4049 | 137.4 (91,089–198,917) | 3378 | 105 (76,706–146) | 671 | < 0.01* |